Last kr243.30 DKK
Change Today -1.00 / -0.41%
Volume 1.8M
NOVOB On Other Exchanges
Symbol
Exchange
Copenhagen
Frankfurt
Frankfurt
As of 11:03 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kåre Schultz

President, Chief Operating Officer and Member of the Senior Management Board, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 3 different industries.

See Board Relationships
52kr8,600,000
As of Fiscal Year 2012

Background*

Mr. Kåre Schultz has been the President and Chief Operating Officer of Novo Nordisk A/S since January 30, 2014 & March 2002 respectively and serves as its Member of the Senior Management Board. Mr. Schultz served as an Executive Vice President of Novo Nordisk A/S. He joined Novo Nordisk A/S in 1989 as an Economist in Health Care, Economy and Planning since November 2000, he served as its Chief of Staff. He serves as Chairman of Royal Unibrew A/S and served as its Member ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Chairman, Chairman of Audit Committee, Chairman of Remuneration Committee and Chairman of Nomination Committee
2007-Present
Member of The Board

Education*

MS 1987
Københavns Universitet

Other Affiliations*

Annual Compensation*

Salarykr5,200,000
Bonuskr1,400,000
Total Annual Compensationkr6,600,000

Stock Options*

All Other Compensationkr2,000,000

Total Compensation*

Total Annual Cash Compensationkr8,600,000
Total Short Term Compensationkr6,600,000
Other Long Term Compensationkr2,000,000
Total Calculated Compensationkr8,600,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr243.30 DKK -1.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.